Desvaux Pierre, Corman André, Hamidi Karim, Pinton Philippe
Service d'Urologie, Hôpital Cochin, Paris, France.
Prog Urol. 2004 Sep;14(4):512-20.
Despite the improved knowledge on erectile dysfunction and its prevalence over recent years, no pharmaco-epidemiology study on the management of erectile dysfunction in daily practice has been performed. This absence of data is all the more regrettable in view of the real revolution in the management of this disorder, leading an increasing number of patients to consult.
To determine and analyse the presenting complaints, aetiological diagnoses, and modalities of management of patients with erectile dysfunction.
PISTES pharmaco-epidemiological, prospective and transverse study of a representative national sample of 411 private or hospital urologists and sexologists between April and June 2002.
The majority of patients (56.7%) expressed discomfort talking about this subject. Patients with mixed predominant psychogenic ED and mixed predominant organic ED represented 67.1% of the population, confirming the multifactorial aetiology. The management varies according to the aetiology. Complementary investigations are essentially hormone assays (89.6%), well ahead of provoked erection tests (21.9%). Patients are reviewed within 2 months and 65% resumed a satisfactory sexual activity. The main causes of failure are inefficacy (83.7%) and the high cost of treatment preventing purchase (56%).
This study shows an effective management of erectile dysfunction, but which is still faced with difficulties of access to care for psychological or economic reasons. These difficulties concern the patient, his partner and the practitioner Although information on erectile dysfunction has been greatly improved, it does not sufficiently encourage effective therapeutic management.
尽管近年来对勃起功能障碍及其患病率的认识有所提高，但尚未开展关于日常临床中勃起功能障碍治疗的药物流行病学研究。鉴于该疾病治疗方面的实际变革，导致越来越多的患者前来咨询，缺乏相关数据就显得尤为遗憾。
确定并分析勃起功能障碍患者的就诊主诉、病因诊断及治疗方式。
PISTES药物流行病学研究，于2002年4月至6月对411名私立或医院的泌尿科医生和性学家组成的具有代表性的全国样本进行了前瞻性横断面研究。
大多数患者（56.7%）表示谈论这个话题时会感到不适。混合性为主的心理性勃起功能障碍和混合性为主的器质性勃起功能障碍患者占总人数的67.1%，证实了病因的多因素性。治疗方式因病因不同而有所差异。辅助检查主要是激素测定（89.6%），远远领先于诱发勃起试验（21.9%）。患者在2个月内接受复查，65%的患者恢复了满意的性活动。治疗失败的主要原因是无效（83.7%）以及治疗费用高昂导致无法购买（56%）。
本研究显示勃起功能障碍的治疗是有效的，但仍因心理或经济原因面临就医困难。这些困难涉及患者、其伴侣和从业者。尽管关于勃起功能障碍的信息有了很大改善，但仍不足以鼓励有效的治疗管理。
